Volgen
Katleen De Preter
Katleen De Preter
full research professor, Ghent University
Geverifieerd e-mailadres voor ugent.be - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
J Vandesompele, K De Preter, F Pattyn, B Poppe, N Van Roy, ...
Genome biology 3, 1-12, 2002
214092002
Mutational dynamics between primary and relapse neuroblastomas
A Schramm, J Köster, Y Assenov, K Althoff, M Peifer, E Mahlow, ...
Nature genetics 47 (8), 872-877, 2015
3652015
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
S De Brouwer, K De Preter, C Kumps, P Zabrocki, M Porcu, ...
Clinical cancer research 16 (17), 4353-4362, 2010
3372010
Evaluation of qPCR curve analysis methods for reliable biomarker discovery: bias, resolution, precision, and implications
JM Ruijter, MW Pfaffl, S Zhao, AN Spiess, G Boggy, J Blom, RG Rutledge, ...
Methods 59 (1), 32-46, 2013
2872013
Benchmarking of cell type deconvolution pipelines for transcriptomics data
F Avila Cobos, J Alquicira-Hernandez, JE Powell, P Mestdagh, ...
Nature communications 11 (1), 5650, 2020
2782020
De preter
J Vandesompele
K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., Speleman, F, 0034.1 …, 2002
2192002
Measurable impact of RNA quality on gene expression results from quantitative PCR
J Vermeulen, K De Preter, S Lefever, J Nuytens, F De Vloed, S Derveaux, ...
Nucleic acids research 39 (9), e63-e63, 2011
2072011
Computational deconvolution of transcriptomics data from mixed cell populations
F Avila Cobos, J Vandesompele, P Mestdagh, K De Preter
Bioinformatics 34 (11), 1969-1979, 2018
2042018
Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay
K De Preter, F Speleman, V Combaret, J Lunec, G Laureys, BHJ Eussen, ...
Modern Pathology 15 (2), 159-166, 2002
2032002
Asthma inflammatory phenotypes show differential microRNA expression in sputum
T Maes, FA Cobos, F Schleich, V Sorbello, M Henket, K De Preter, ...
Journal of Allergy and Clinical Immunology 137 (5), 1433-1446, 2016
1992016
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
LC Heukamp, T Thor, A Schramm, K De Preter, C Kumps, B De Wilde, ...
Science translational medicine 4 (141), 141ra91-141ra91, 2012
1982012
Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma
J Vandesompele, M Baudis, K De Preter, N Van Roy, P Ambros, N Bown, ...
Journal of clinical oncology 23 (10), 2280-2299, 2005
1982005
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
J Vermeulen, K De Preter, A Naranjo, L Vercruysse, N Van Roy, ...
The lancet oncology 10 (7), 663-671, 2009
1922009
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
K De Preter, J Vandesompele, P Heimann, N Yigit, S Beckman, ...
Genome biology 7, 1-17, 2006
1922006
Targeting MYCN-driven transcription by BET-bromodomain inhibition
A Henssen, K Althoff, A Odersky, A Beckers, R Koche, F Speleman, ...
Clinical Cancer Research 22 (10), 2470-2481, 2016
1792016
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours
P Mestdagh, E Fredlund, F Pattyn, A Rihani, T Van Maerken, J Vermeulen, ...
Oncogene 29 (24), 3583-3592, 2010
1782010
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
P Mestdagh, E Fredlund, F Pattyn, JH Schulte, D Muth, J Vermeulen, ...
Oncogene 29 (9), 1394-1404, 2010
1502010
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
K Althoff, A Beckers, E Bell, M Nortmeyer, T Thor, A Sprüssel, S Lindner, ...
Oncogene 34 (26), 3357-3368, 2015
1462015
High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
JH Schulte, HS Bachmann, B Brockmeyer, K DePreter, A Oberthür, ...
Clinical Cancer Research 17 (15), 5082-5092, 2011
1322011
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
DR Carter, J Murray, BB Cheung, L Gamble, J Koach, J Tsang, S Sutton, ...
Science translational medicine 7 (312), 312ra176-312ra176, 2015
1302015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20